Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricRMDResMedGEHCGE HealthCareDXCMDexcom
Snapshot
Price$233.33$71.22$90.10
Market cap$30.41B$29.82B$27.49B
Valuation
P/E22.3x17.4x37.7x
Forward P/E19.1x19.8x26.9x
Growth
Revenue growth10.3%6.0%16.1%
EPS growth16.5%-12.3%77.5%
Profitability
Net margin27.4%9.1%19.3%
ROE24.4%18.8%33.8%
Balance sheet & cash
Debt / equity0.11x0.97x0.47x
Free cash flow yield3.8%7.7%1.8%
Dividend yield1.2%0.2%—
Verdict
Investment ratingStrong· 75Neutral· 51Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearRMDtoday $233GEHCtoday $71DXCMtoday $90
2027$203.82 – $298.94+28% CAGR$54.48 – $79.91+12% CAGR$119.91 – $175.87+95% CAGR
2028$237.39 – $348.17+22% CAGR$55.57 – $81.51+7% CAGR$212.78 – $312.08+86% CAGR
2029$276.49 – $405.51+20% CAGR$56.68 – $83.14+5% CAGR$377.58 – $553.79+83% CAGR
2030$322.02 – $472.30+19% CAGR$57.82 – $84.80+4% CAGR$670.02 – $982.70+82% CAGR
2031$375.06 – $550.09+19% CAGR$58.97 – $86.50+4% CAGR$1,188.96 – $1,743.80+81% CAGR
5-yr CAGR10.0% – 18.7%-3.7% – 4.0%67.5% – 80.9%